Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia

Metabolic Brain Disease

Volumn 30, Issue 4, 2015, Pages 1043-1053

  Zugno, Alexandra Ioppi ^a   Pacheco, Felipe Damázio ^a   Budni, Josiane ^a   de Oliveira, Mariana Bittencourt ^a   Canever, Lara ^a   Heylmann, Alexandra Stephanie ^a   Wessler, Patrícia Gomes ^a   da Rosa Silveira, Flávia ^a   Mastella, Gustavo Antunes ^a   Gonçalves, Cinara Ludwig ^a   Freitas, Karoline V ^a   de Castro, Adalberto Alves ^a   Streck, Emilio L ^a   Quevedo, João ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Creatine kinase; Krebs cycle; Maternal deprivation; Mitochondrial respiratory chain; Oxidative stress; Schizophrenia

Indexed keywords

BRAIN DERIVED GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBONYL DERIVATIVE; CREATINE KINASE; CYTOCHROME C OXIDASE; KETAMINE; MALATE DEHYDROGENASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); THIOBARBITURIC ACID REACTIVE SUBSTANCE; UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; CORPUS STRIATUM; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; MALE; MATERNAL DEPRIVATION; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PREFRONTAL CORTEX; PROTEIN CARBONYLATION; RAT; SCHIZOPHRENIA; ANIMAL; BRAIN; CHEMICALLY INDUCED; DRUG EFFECTS; HOMEOSTASIS; METABOLISM; MITOCHONDRION; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BRAIN; ENERGY METABOLISM; FEMALE; HOMEOSTASIS; KETAMINE; MALE; MATERNAL DEPRIVATION; MITOCHONDRIA; OXIDATIVE STRESS; RATS; RATS, WISTAR; SCHIZOPHRENIA;

EID: 84956883097     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-015-9671-3     Document Type: Article

References (68)

1. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ (1989) Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52(5):1655–1658
2. Abi-Dargham A, Laruelle M (2005) Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur Psychiatry 20:15–27. doi:10.1016/j.clinthera.2005.07.017
3. Beatty PA, Beatty WW, Bowman RE, Gilchrist JC (1970) The effects of ACTH, adrenalectomy and dexamethasone on the acquisition of an avoidance response in rats. Physiol Behav 5:939–944
4. Becker A, Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuropsychopharmacol Biol Psychiatry 28(8):1267–1277. doi:10.1016/j.pnpbp.2004.06.019
5. Becker A, Peters B, Schroeder H, Mann T, Huether G, Grecksch G (2003) Ketamine-induced changes in rat behavior: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:687–700. doi:10.1016/S0278-5846(03)00080-0
6. Ben-Shachar D (2002) Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 83:1241–1251. doi:10.1046/j.1471-4159.2002.01263
7. Ben-Shachar D, Laifenfeld D (2003) Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol 59:273–296. doi:10.1016/S0074-7742(04)59011-6
8. Ben-Shachar D, Laifenfeld D (2004) Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol 59:273–296. doi:10.1016/S0074-7742(04)59011-6
9. Bickel S, Javitt DC (2009) Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate. Behav Brain Res 204:352–362. doi:10.1016/j.bbr.2009.05.005
10. Bitanihirwe BKY, Woo TUW (2011) Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 35(3):878–893. doi:10.1016/j.neubiorev.2010.10.008
11. Boekema EJ, Braun HP (2007) Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Biol Chem 282:1–4. doi:10.1074/jbc.R600031200
12. Bradford A (2009) The dopamine and glutamate theories of schizophrenia: a short review. Curr Anaesthesiol Crit Care 20:240–241
13. Brenner-Lavie H, Klein E, Ben-Shachar D (2009) Mitochondrial complex I as a novel target for intraneuronal DA: modulation of respiration in intact cells. Biochem Pharmacol 78:85–95. doi:10.1016/j.bcp.2009.03.024
14. Bressan RA, Pilowsky LS (2003) Hipótese glutamatérgica da esquizofrenia. Rev Bras Psiquiatr 25:177–183. doi:10.1590/S1516-44462003000300011
15. Brown AS (2011) The environment and susceptibility do schizophrenia. Prog Neurobiol 93(1):23–58. doi:10.1016/j.pneurobio.2010.09.003
16. Bubber P, Hartounian V, Gibson GE, Blass JP (2011) Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol 21(3):254–260. doi:10.1016/j.euroneuro.2010.10.007
17. Bubeníková-Valešová V, Horáček J, Vrajová M, Höschl C (2008) Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 38:1014–1023. doi:10.1016/j.neubiorev.2008.03.012
18. Burbaeva GS, Savushkina OK, Boksha IS (2003) Creatine kinase BB in brain in schizophrenia. World J Biol Psychiatry 4(4):177–183
19. Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind RA, Borrelli E, Bernardi G (2001) Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci 21(14):5110–5120
20. Cassina A, Radi R (1996) Differential inhibitory Action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328:309–316
21. Cavelier L, Jazin E, Eriksson I, Prince J, Bave U, Oreland L, Gyllensten U (1995) Decreased cytochrome c oxidase activity and lack of age related accumulation of mtDNA in brain of schizophrenics. Genomics 29:217–228. doi:10.1006/geno.1995.1234
22. De Oliveira L, Fraga DB, De Luca RD, Canever L, Ghedim FV, Matos MP, Streck EL, Quevedo J, Zugno AI (2011) Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine. Met Brain Dis 26:69–77
23. Dietrich-Muszalska A, Kontek B (2010) Lipid peroxidation in patients with schizophrenia. Psychiatry Clin Neurosci 64(5):469–475. doi:10.1111/j.1440-1819.2010.02132.x
24. Doherty MDH, Gratton A (1997) NMDA receptors in nucleus accumbens modulate stress-induced dopamine release in nucleus accumbens and ventral tegmental area. Synapse 26(3):225–234
25. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431
26. Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153:23–36
27. Fuchikami M, Yamamoto S, Morinobu S, Takei S, Yamawaki S (2010) Epigenetic regulation of BDNF gene in response to stress. Psychiatry Investig 7:251–256. doi:10.4306/pi.2010.7.4.251
28. Garcia LB, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries G, Gavioli E, Kapczinski F, Quevedo J (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog-Neuropsychopharmacol Biol Psychiatry. 32:140–144
29. Garcia LS, Comim CM, Valvassori SS, Réus GZ, Stertz L, Kapczinski F, Gavioli EC, Quevedo J (2009) Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 33(3):450–455. doi:10.1016/j.pnpbp.2009.01.004
30. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ (2013) Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. J Psychiatr Res 47(6):740–746. doi:10.1038/mp.2010.88
31. Hughes BP (1962) A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clin Chim 7:597–604
32. Hunt MJ, Raynaud B, Garcia R (2006) Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats. Biol Psychiatry 60(11):1206–1214. doi:10.1016/j.biopsych.2006.01.020
33. Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP (2002) Reduced erythrocyte membrane essential fatty acidsand increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res 58(1):1–10. doi:10.1016/S0920-9964(01)00334-6
34. Kitto GB (1969) Intra and extra mitochondrial malate dehydrogenases from chicken and tuna heart. Methods Enzymol 13:106–116
35. Kunz M, Gama CS, Andreazza AC, Salvador M, Ceresér KM, Gomes FA, Belmonte-de-Abreu PS, Berk M, Kapczinski F (2008) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32(7):1677–1681. doi:10.1016/j.pnpbp.2008.07.001
36. Levine RL, Garland D, Oliver CN (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478
37. Liu F, Patterson TA, Sadovova N, Zhang X, Liu S, Zou X, Hanig JP, Paule MG, Slikker W Jr, Wang C (2013) Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture. Toxicol Sci 131(2):548–557. doi:10.1093/toxsci/kfs296
38. Lowry OH, Rosebrough AL, Randal RJ (1951) Protein measurement with the folinphenol reagent. J Biol Chem 193:265–275
39. Lyubarev AE, Kurganov BI (1989) Supramolecular organization of tricarboxylic acid cycle enzymes. Biosystems 22:91–102
40. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17(3):141–150
41. Maurer I, Zierz S, Möller HJ (2001) Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 48:125–136. doi:10.1016/S0920-9964(00)00075-X
42. McEwen BS (2000) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886(1–2):172–189. doi:10.1016/S0006-8993(00)02950-4
43. Mello PB, Benetti F, Cammarota M, Izquierdo I (2009) Physical exercise can reverse the deficit in fear memory induced by maternal deprivation. Neurobiol Learn Mem 92:364–369. doi:10.1016/j.nlm.2009.04.004
44. Meyer-Lindenberg A, Miletich RS, Kohn PD, Richard GE, Carson E, Quarantelli M, Weinberger DR, Berman KF (2002) Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5(3):267–271. doi:10.1038/nn804
45. Mifsud KR, Gutièrrez-Mecinas M, Trollope AF, Collins A, Saunderson EA, Reul JMHM (2011) Epigenetic mechanisms in stress and adaptation. Brain Behav Immun 25:1305–1315. doi:10.1016/j.bbi.2011.06.005
46. Moghaddam B, Jackson M (2003) Glutamatergic animal models of schizophrenia. Ann N Y Acad Sci 1003:131–137. doi:10.1196/annals.1300.065
47. Morgan CJ, Mofeez BB, Bromley L, Curran HV (2004) Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29:208–218. doi:10.1038/sj.npp.1300342
48. Nakazawa K, Zsiros V, Jiang Z, Nakao K, Kolata S, Zhang S, Belforte JE (2012) Gabaergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 62(3):1574–1583. doi:10.1016/j.neuropharm.2011.01.022
49. Pochwat B, Szewczyk B, Sowa-Kucma M, Siwek A, Doboszewska U, Piekoszewski W, Gruca P, Papp M, Nowak G (2014) Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. Int J Neuropsychopharmacol 17(3):393–405. doi:10.1017/S1461145713001089
50. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JTJ, Griffin JL (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684–697. doi:10.1038/sj.mp.4001511
51. Prince JA, Oreland L (1998) Mitochondrial activity in the mapping of functional brain changes in schizophrenia. Restor Neurol Neurosci 12(2–3):185–193
52. Prince JA, Blennow K, Gottfries CG, Karlsson I, Oreland L (1999) Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21(3):372–379. doi:10.1016/S0893-133X(99)00016-0
53. Radonjić NV, Knezević ID, Vilimanovich U, Kravić-Stevović T, Marina LV, Nikolić T, Todorović V, Bumbasirević V, Petronijević ND (2010) Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration. Neuropharmacology 58(4–5):739–745. doi:10.1016/j.neuropharm.2009.12.009
54. Rezin GT, Gonçalves CL, Daufenbach JF, Fraga DB, Santos PM, Ferreira GK, Hermani FV, Comim CM, Quevedo J, Streck EL (2009) Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress. Brain Res Bull 79(6):418–421
55. Réus GZ, Stringari RB, Ribeiro F, Cipriano AL, Panizzutti BS, Stertz L, Lersch C, Kapczinski F, Quevedo J (2011) Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain. Neurochem Res 36(3):460–466. doi:10.1007/s11064-010-0364-3
56. Réus GZ, Nacif MP, Abelaira HM, Tomaz DB, Dos Santos MA, Carlessi AS, Matias BI, da Luz JR, Steckert AV, Jeremias GC, Scaini G, Morais MO, Streck EL, Quevedo J (2015) Ketamine treatment partly reverses alterations in brain derived-neurotrophic factor, oxidative stress and energy metabolism parameters induced by an animal model of depression. Curr Neurovasc Res 12(1):73–84
57. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM, Munnich A (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35–51
58. Snyder MA, Gao WJ (2013) NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia. Front Cell Neurosci 7:31. doi:10.3389/fncel.2013.00031
59. Takase K, Yamamoto Y, Yagami T (2012) Maternal deprivation in the middle of a stress hyporesponsive period decreases hippocampal calcineurin expression and causes abnormal social and cognitive behaviours in adult male Wistar rats: relevance to negative symptoms of schizophrenia. Behav Brain Res 232(1):306–315. doi:10.1016/j.bbr.2012.04.016
60. Uysal N, Gonenc S, Acikgoz O, Pekçetin C, Kayatekin BM, Sonmez A, Semin I (2005) Age- dependent effects of maternal deprivation on oxidative stress in infant rat brain. Neurosci Lett 384(1–2):98–101. doi:10.1016/j.neulet.2005.04.052
61. Velot C, Mixon MB, Teige M, Srere PA (1997) Model of a quinary structure between Krebs TCA cycle enzymes: A model for the metabolon. Biochemistry 36(47):14271–14276
62. Waddington JL (1993) Schizophrenia: developmental neuroscience and pathobiology. Lancet 8844:531–536. doi:10.1016/0140-6736(93)90288-R
63. Xiong P, Zeng Y, Zhu Z, Tan D, Xu F, Lu J, Wan J, Ma M (2010) Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia. Schizophr Res 119(1–3):34–39
64. Xiong P, Zeng Y, Wan J, Xiaohan DH, Tan D, Lu J, Xu F, Li HY, Zhu Z, Ma M (2011) The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia. Psychiatry Res 189(1):72–76. doi:10.1016/j.psychres.2010.12.017
65. Yadava N, Nicholls DG (2007) Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J Neurosci 27(27):7310–7317. doi:10.1016/j.schres.2010.02.1063
66. Yatin SM, Aksenov M, Butterfield DA (1999) The antioxidant vitamin E modulates amyloid B peptide- induced CK activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer’s disease. Neurochem Res 24(3):427–435
67. Zugno AI, de Miranda IM, Budni J, Volpato AM, Luca RD, Deroza PF, de Oliveira MB, Heylmann AS, da Rosa SF, Wessler P, Antunes Mastella G, Cipriano AL, Quevedo J (2013) Effect of maternal deprivation on acetylcholinesterase activity and behavioral changes on the ketamine-induced animal model of schizophrenia. Neuroscience 248C:252–260. doi:10.1016/j.neuroscience.2013.05.059
68. Zugno AI, Chipindo HL, Volpato AM, Budni J, Steckert AV, de Oliveira MB, Heylmann AS, da Rosa SF, Mastella GA, Maravai SG, Wessler PG, Binatti AR, Panizzutti B, Schuck PF, Quevedo J, Gama CS (2014) Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia. Neuroscience 259:223–231. doi:10.1016/j.neuroscience.2013.11.049